Shares of Integer Holdings (NYSE: ITGR) closed Friday at $121.21, a gain of 20.2%, following reports that KKR (NYSE: KKR) is in advanced discussions to acquire the medical device component manufacturer. The stock's rally came on volume that was 6.1 times its 20-session average, reaching a 52-week high of $123.50 during the session.
The Wall Street Journal reported a potential price near $127 per share, while the Financial Times cited a range of $125 to $130. The reports suggest that a deal could be announced as early as next week, potentially aligning with Integer's second-quarter earnings release scheduled for August 6. This has created a highly binary week for investors, with the outcome of the negotiations likely to determine the stock's near-term trajectory.
At Friday's closing price, the reported offer of $127 represents a gross premium of just 4.8%, leaving a narrow spread of $5.79. This tight spread reflects the market's assessment of deal completion risk. Based on the closing price, preliminary calculations suggest a completion probability of approximately 78%, though this figure decreases as the reported offer price increases. For instance, a $130 offer would imply a 70% probability, while a $125 offer suggests an 84% likelihood. These estimates are derived from a risk-arbitrage model and do not account for time value, dilution, or potential balance-sheet adjustments.
The potential acquisition would value Integer at approximately $4.31 billion based on the $127 offer, translating to an EV/EBITDA multiple of 14.4 times the company's projected 2026 adjusted EBITDA. This is a significant premium to the average analyst price target of $106, which had been based on the company's standalone earnings outlook. The rally has shifted the market's focus from earnings-based valuations to transaction terms, with the stock now trading above even the highest analyst target of $115.
Integer's strategic review, announced on April 30, followed expressions of interest from potential buyers. Chair Pamela G. Bailey stated at the time that it was "the right time to consider all opportunities," though the board did not provide a timeline or guarantee a deal. The company has faced pressure from activist investor Irenic Capital Management, which holds a 3.72% stake and had urged a sale. In March, Integer appointed two new board members as part of an agreement with the activist.
The company's recent financial performance has been mixed. First-quarter revenue rose 0.5% to $440 million, but adjusted EBITDA fell 7% to $85 million, and adjusted earnings per share declined 8% to $1.20. Net debt stood at $1.264 billion, representing leverage of 3.2 times adjusted EBITDA. In April, management lowered its full-year 2026 guidance across all key metrics, with CEO Payman Khales citing the need to "further risk adjust our outlook." The revised guidance projects sales of $1.820 billion, adjusted operating income of $295 million, adjusted EBITDA of $387 million, adjusted EPS of $6.12, and operating cash flow of $195 million.
Investors now face two potential catalysts in the coming week: a possible deal announcement and the earnings report. If negotiations collapse, shares could fall back toward their pre-announcement level of $100.86, a decline of 16.8%. Conversely, a confirmed deal at the reported price would offer a modest but relatively low-risk return. The situation remains fluid, and neither KKR nor Integer has commented on the reports. The lack of details on financing, terms, or regulatory timeline adds to the uncertainty, but the market's reaction suggests that many investors are betting on a successful outcome.
